Profile - To The Moon

leejar

Posts · 13Posts · 13
Following · 0Following · 0
Followers · 0Followers · 0

- leejarleejar
  ·2021-07-30
  Good
  Sorry, this post has been deleted
  2.66K Comment
  4
  Share
  Report
- leejarleejar
  ·2021-07-29
  AMD
  Sorry, this post has been deleted
  4.25K 2
  2
  Share
  Report
- leejarleejar
  ·2021-07-29
  Will it go up further?
  Why AMD's Stock Is Trading Higher Today
  AMD is trading higher Wednesday morning after the company late Tuesday announced better-than-expecte
  Why AMD's Stock Is Trading Higher Today
  2.76K Comment
  4
  Share
  Report
- leejarleejar
  ·2021-07-28
  Will price continue drop?
  Sorry, this post has been deleted
  2.74K Comment
  4
  Share
  Report
- leejarleejar
  ·2021-07-14
  Cool
  Sorry, this post has been deleted
  3.27K 1
  6
  Share
  Report
- leejarleejar
  ·2021-07-14
  Good
  UK nod paves way for AstraZeneca-Alexion deal to close next week
  July 14 (Reuters) - AstraZeneca's $39 billion buyout of U.S.-based rare diseases business Alexion is
  UK nod paves way for AstraZeneca-Alexion deal to close next week
  3.30K 1
  2
  Share
  Report
- leejarleejar
  ·2021-07-09
  How about tonight?
  Sorry, this post has been deleted
  3.30K 2
  5
  Share
  Report
- leejarleejar
  ·2021-07-09
  Up
  Sorry, this post has been deleted
  3.27K 2
  4
  Share
  Report
No followers yet

Most Discussed

{"i18n":{"language":"en_US"},"isCurrentUser":false,"userPageInfo":{"id":"3573163440773605","uuid":"3573163440773605","gmtCreate":1610071420190,"gmtModify":1610071420190,"name":"leejar","pinyin":"leejar","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":5,"headSize":56,"tweetSize":13,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.02.16","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"wearingSort":0},{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.01.30","exceedPercentage":"80.98%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"wearingSort":0},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"wearingSort":0},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"wearingSort":0}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":12,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":808266213,"gmtCreate":1627596554732,"gmtModify":1703492902470,"author":{"id":"3573163440773605","authorId":"3573163440773605","name":"leejar","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573163440773605","idStr":"3573163440773605"},"themes":[],"title":"","htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/808266213","repostId":"1131907757","repostType":4,"isVote":1,"tweetType":1,"viewCount":2659,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":801639519,"gmtCreate":1627514052631,"gmtModify":1703491287653,"author":{"id":"3573163440773605","authorId":"3573163440773605","name":"leejar","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573163440773605","idStr":"3573163440773605"},"themes":[],"title":"","htmlText":"AMD","listText":"AMD","text":"AMD","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/801639519","repostId":"1148922985","repostType":4,"isVote":1,"tweetType":1,"viewCount":4247,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":801630543,"gmtCreate":1627514011482,"gmtModify":1703491286194,"author":{"id":"3573163440773605","authorId":"3573163440773605","name":"leejar","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573163440773605","idStr":"3573163440773605"},"themes":[],"title":"","htmlText":"Will it go up further?","listText":"Will it go up further?","text":"Will it go up further?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/801630543","repostId":"2154721924","repostType":4,"repost":{"id":"2154721924","kind":"highlight","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1627486574,"share":"https://ttm.financial/m/news/2154721924?lang=en_US&edition=fundamental","pubTime":"2021-07-28 23:36","market":"hk","language":"en","title":"Why AMD's Stock Is Trading Higher Today","url":"https://stock-news.laohu8.com/highlight/detail?id=2154721924","media":"Tiger Newspress","summary":"AMD is trading higher Wednesday morning after the company late Tuesday announced better-than-expecte","content":"<p>AMD is trading higher Wednesday morning after the company late Tuesday announced better-than-expected second-quarter financial results and issued third-quarter guidance above estimates.</p>\n<p>AMD reported quarterly earnings of 63 cents per share, which beat the estimate of 54 cents per share. The company reported quarterly revenue of $3.85 billion, which beat the estimate of $3.62 billion. AMD said it expects third-quarter revenue to be in a range of $4 billion to $4.2 billion, which was&nbsp;higher than the estimate of $3.82 billion.</p>\n<p>\"Our business performed exceptionally well in the second quarter as revenue and operating margin doubled and profitability more than tripled year-over-year,” said Lisa Su,&nbsp;president and CEO of AMD.</p>\n<p><b>Analyst Assessment:</b>&nbsp;Rosenblatt analyst Hans Mosesmann maintained&nbsp;AMD&nbsp;with a Buy rating and raised&nbsp;the price target from&nbsp;$135&nbsp;to&nbsp;$150.</p>\n<p>Susquehanna analyst Christopher Rolland maintained&nbsp;AMD&nbsp;with a Positive rating and raised&nbsp;the price target from&nbsp;$125&nbsp;to&nbsp;$130.</p>\n<p><b>Price Action: </b>AMD has traded as high as $99.23 and as low as $67.02 over a 52-week period.</p>\n<p>At last check Wednesday, the stock was up 5% at $95.6.</p>\n<p><img src=\"https://static.tigerbbs.com/a0dd3dd7be87bfa480b05a3c26ee3f62\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why AMD's Stock Is Trading Higher Today</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy AMD's Stock Is Trading Higher Today\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-07-28 23:36</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>AMD is trading higher Wednesday morning after the company late Tuesday announced better-than-expected second-quarter financial results and issued third-quarter guidance above estimates.</p>\n<p>AMD reported quarterly earnings of 63 cents per share, which beat the estimate of 54 cents per share. The company reported quarterly revenue of $3.85 billion, which beat the estimate of $3.62 billion. AMD said it expects third-quarter revenue to be in a range of $4 billion to $4.2 billion, which was&nbsp;higher than the estimate of $3.82 billion.</p>\n<p>\"Our business performed exceptionally well in the second quarter as revenue and operating margin doubled and profitability more than tripled year-over-year,” said Lisa Su,&nbsp;president and CEO of AMD.</p>\n<p><b>Analyst Assessment:</b>&nbsp;Rosenblatt analyst Hans Mosesmann maintained&nbsp;AMD&nbsp;with a Buy rating and raised&nbsp;the price target from&nbsp;$135&nbsp;to&nbsp;$150.</p>\n<p>Susquehanna analyst Christopher Rolland maintained&nbsp;AMD&nbsp;with a Positive rating and raised&nbsp;the price target from&nbsp;$125&nbsp;to&nbsp;$130.</p>\n<p><b>Price Action: </b>AMD has traded as high as $99.23 and as low as $67.02 over a 52-week period.</p>\n<p>At last check Wednesday, the stock was up 5% at $95.6.</p>\n<p><img src=\"https://static.tigerbbs.com/a0dd3dd7be87bfa480b05a3c26ee3f62\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMD":"美国超微公司"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2154721924","content_text":"AMD is trading higher Wednesday morning after the company late Tuesday announced better-than-expected second-quarter financial results and issued third-quarter guidance above estimates.\nAMD reported quarterly earnings of 63 cents per share, which beat the estimate of 54 cents per share. The company reported quarterly revenue of $3.85 billion, which beat the estimate of $3.62 billion. AMD said it expects third-quarter revenue to be in a range of $4 billion to $4.2 billion, which was higher than the estimate of $3.82 billion.\n\"Our business performed exceptionally well in the second quarter as revenue and operating margin doubled and profitability more than tripled year-over-year,” said Lisa Su, president and CEO of AMD.\nAnalyst Assessment: Rosenblatt analyst Hans Mosesmann maintained AMD with a Buy rating and raised the price target from $135 to $150.\nSusquehanna analyst Christopher Rolland maintained AMD with a Positive rating and raised the price target from $125 to $130.\nPrice Action: AMD has traded as high as $99.23 and as low as $67.02 over a 52-week period.\nAt last check Wednesday, the stock was up 5% at $95.6.","news_type":1,"symbols_score_info":{"AMD":0.9}},"isVote":1,"tweetType":1,"viewCount":2762,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":803191378,"gmtCreate":1627427074394,"gmtModify":1703489555849,"author":{"id":"3573163440773605","authorId":"3573163440773605","name":"leejar","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573163440773605","idStr":"3573163440773605"},"themes":[],"title":"","htmlText":"Will price continue drop?","listText":"Will price continue drop?","text":"Will price continue drop?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/803191378","repostId":"1148712151","repostType":4,"isVote":1,"tweetType":1,"viewCount":2735,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":145754921,"gmtCreate":1626249104363,"gmtModify":1703756309324,"author":{"id":"3573163440773605","authorId":"3573163440773605","name":"leejar","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573163440773605","idStr":"3573163440773605"},"themes":[],"title":"","htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/145754921","repostId":"2151442598","repostType":4,"isVote":1,"tweetType":1,"viewCount":3274,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":145755818,"gmtCreate":1626249060534,"gmtModify":1703756307195,"author":{"id":"3573163440773605","authorId":"3573163440773605","name":"leejar","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573163440773605","idStr":"3573163440773605"},"themes":[],"title":"","htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/145755818","repostId":"2151592351","repostType":4,"repost":{"id":"2151592351","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1626246243,"share":"https://ttm.financial/m/news/2151592351?lang=en_US&edition=fundamental","pubTime":"2021-07-14 15:04","market":"us","language":"en","title":"UK nod paves way for AstraZeneca-Alexion deal to close next week","url":"https://stock-news.laohu8.com/highlight/detail?id=2151592351","media":"Reuters","summary":"July 14 (Reuters) - AstraZeneca's $39 billion buyout of U.S.-based rare diseases business Alexion is","content":"<p>July 14 (Reuters) - AstraZeneca's $39 billion buyout of U.S.-based rare diseases business Alexion is expected to close next week as Britain's competition watchdog cleared the deal on Wednesday.</p>\n<p>The merger, which will beef up the AstraZeneca's line of cancer medicines, is expected to close on July 21, the drugmaker, a major COVID-19 vaccine producer, said.</p>\n<p>The Competition and Markets Authority began a review of the deal in May to check if that could reduce competition in Britain or other markets.</p>\n<p>It decided not to initiate a broader probe into the deal following its initial assessment. The clearance follows that from Europe earlier this month.</p>\n<p>\"We are very pleased to have secured this critical final clearance,\" said finance chief Marc Dunoyer.</p>\n<p>A management shake-up at AstraZeneca following the completion of the merger is expected.</p>\n<p>The Anglo-Swedish drugmaker had said it would move Dunoyer to head Alexion, while Aradhana Sarin will move in the opposite direction to be AstraZeneca's finance head.</p>\n<p>The drugmaker said it plans to give updated 2021 outlook for the combined company \"in due course\".</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>UK nod paves way for AstraZeneca-Alexion deal to close next week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUK nod paves way for AstraZeneca-Alexion deal to close next week\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-14 15:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>July 14 (Reuters) - AstraZeneca's $39 billion buyout of U.S.-based rare diseases business Alexion is expected to close next week as Britain's competition watchdog cleared the deal on Wednesday.</p>\n<p>The merger, which will beef up the AstraZeneca's line of cancer medicines, is expected to close on July 21, the drugmaker, a major COVID-19 vaccine producer, said.</p>\n<p>The Competition and Markets Authority began a review of the deal in May to check if that could reduce competition in Britain or other markets.</p>\n<p>It decided not to initiate a broader probe into the deal following its initial assessment. The clearance follows that from Europe earlier this month.</p>\n<p>\"We are very pleased to have secured this critical final clearance,\" said finance chief Marc Dunoyer.</p>\n<p>A management shake-up at AstraZeneca following the completion of the merger is expected.</p>\n<p>The Anglo-Swedish drugmaker had said it would move Dunoyer to head Alexion, while Aradhana Sarin will move in the opposite direction to be AstraZeneca's finance head.</p>\n<p>The drugmaker said it plans to give updated 2021 outlook for the combined company \"in due course\".</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ALXN":"亚力兄制药","AZN":"阿斯利康"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2151592351","content_text":"July 14 (Reuters) - AstraZeneca's $39 billion buyout of U.S.-based rare diseases business Alexion is expected to close next week as Britain's competition watchdog cleared the deal on Wednesday.\nThe merger, which will beef up the AstraZeneca's line of cancer medicines, is expected to close on July 21, the drugmaker, a major COVID-19 vaccine producer, said.\nThe Competition and Markets Authority began a review of the deal in May to check if that could reduce competition in Britain or other markets.\nIt decided not to initiate a broader probe into the deal following its initial assessment. The clearance follows that from Europe earlier this month.\n\"We are very pleased to have secured this critical final clearance,\" said finance chief Marc Dunoyer.\nA management shake-up at AstraZeneca following the completion of the merger is expected.\nThe Anglo-Swedish drugmaker had said it would move Dunoyer to head Alexion, while Aradhana Sarin will move in the opposite direction to be AstraZeneca's finance head.\nThe drugmaker said it plans to give updated 2021 outlook for the combined company \"in due course\".","news_type":1,"symbols_score_info":{"AZN":0.9,"ALXN":0.9}},"isVote":1,"tweetType":1,"viewCount":3303,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":143809488,"gmtCreate":1625785988944,"gmtModify":1703748360030,"author":{"id":"3573163440773605","authorId":"3573163440773605","name":"leejar","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573163440773605","idStr":"3573163440773605"},"themes":[],"title":"","htmlText":"How about tonight?","listText":"How about tonight?","text":"How about tonight?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/143809488","repostId":"1153646457","repostType":4,"isVote":1,"tweetType":1,"viewCount":3296,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":143800488,"gmtCreate":1625785944244,"gmtModify":1703748358896,"author":{"id":"3573163440773605","authorId":"3573163440773605","name":"leejar","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573163440773605","idStr":"3573163440773605"},"themes":[],"title":"","htmlText":"Up","listText":"Up","text":"Up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/143800488","repostId":"1191095209","repostType":4,"isVote":1,"tweetType":1,"viewCount":3268,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"followers","isTTM":true}